Publications of Ilona Behrendt

Journal Article (8)

2021
Journal Article
Gränicher, G., Tapia, F., Behrendt, I., Jordan, I., Genzel, Y., & Reichl, U. (2021)Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector ProductionBiotechnology Journal, 16 (1), e2000024doi: 10.1002/biot.202000024.
2019
Journal Article
Coronel, J., Behrendt, I., Bürgin, T., Anderlei, T., Sandig, V., Reichl, U., & Genzel, Y. (2019)Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systemsVaccine, 37 (47), 7011–7018doi: 10.1016/j.vaccine.2019.06.005.
2014
Journal Article
Genzel, Y., Vogel, T., Buck, J., Behrendt, I., Vazquez-Ramirez, D., Schiedner, G., Jordan, I., & Reichl, U. (2014)High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cellsVaccine, 32 (24), 2770–2781doi: 10.1016/j.vaccine.2014.02.016.
Journal Article
Tapia, F., Vogel, T., Genzel, Y., Behrendt, I., Hirschel, M., Gangemi, J. D., & Reichl, U. (2014)Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactorVaccine, 32 (8), 1003–1011doi: 10.1016/j.vaccine.2013.11.044.
2013
Journal Article
Frensing, T., Heldt, S., Pflugmacher, A., Behrendt, I., Jordan, I., Flockerzi, D., Genzel, Y., & Reichl, U. (2013)Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering ParticlesPLoS One, 8 (9), e72288doi: 10.1371/journal.pone.0072288.
Journal Article
Genzel, Y., Behrendt, I., Rödig, J., Rapp, E., Kueppers, C., Kochanek, S., Schiedner, G., & Reichl, U. (2013)CAP, a new human suspension cell line for influenza virus productionApplied Microbiology and Biotechnology, 97 (1), 111–122doi: 10.1007/s00253-012-4238-2.
2010
Journal Article
Lohr, V., Genzel, Y., Behrendt, I., Scharfenberg, K., & Reichl, U. (2010)A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactorVaccine, 28 (38), 6256–6264doi: 10.1016/j.vaccine.2010.07.004.
2004
Journal Article
Genzel, Y., Behrendt, I., König, S., Sann, H., & Reichl, U. (2004)Metabolism of MDCK Cells during cell growth and influenza virus production in large-scale microcarrier cultureVaccine, 22, 2202–2208doi: 10.1016/j.vaccine.2003.11.041.

Meeting Abstract (3)

2022
Meeting Abstract
Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U. (2022)Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionIn: Proceedings Single-Use Technologies V: Building the Future, 40.
Meeting Abstract
Zinnecker, T. M., Behrendt, I., Lau, M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U. (2022)Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactorsIn: Proceedings Vaccine Technology VIII, 55.
2018
Meeting Abstract
Coronel, J., Genzel, Y., Reichl, U., Behrendt, I., Buergin, T., Andereli, T., & Sandig, V. (2018)Orbital shaken bioreactor for influenza A virus production in high cell density cultivationsIn: Vaccine Technology VII, 40.

Talk (7)

2022
Talk
Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U.Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionPresented at: Single-Use Technologies V: Building the FutureMarseille, France, March 20, 2022.
Talk
Zinnecker, T. M., Behrendt, I., Lau , M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U.Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactorsPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.
2016
Talk
Vazquez-Ramirez, D., Nikolay, A., Behrendt, I., Jordan, I., Bürgin, T., Genzel, Y., & Reichl, U.High-cell-density cultivations by hollow fiber-based perfusion for intensified viral vaccine productionPresented at: VII SLATCC meeting Cocoyoc, Morelos, Mexico, November 3, 2016.
2013
Talk
Genzel, Y., Behrendt, I., Vogel, T., Jordan, I., & Reichl, U.Perfusion über das ATF System: Influenza Virusproduktion in HochzelldichtePresented at: GVC/DECHEMA: Effiziente Verfahren und Anlagen in der Bioverfahrenstechnik und LebensmittelbiotechnologieBad Wildungen, Germany, May 6, 2013.
2012
Talk
Genzel, Y., Lohr, V., Behrendt, I., Scharfenberg, K., Kamen, A., Schiedner, G., Jordan, I., & Reichl, U.Cell culture-based influenza virus production: suspension or adherent producer cell lines?Presented at: Cell line development and engineering 2012Cologne, Germany, February 13, 2012.
Talk
Genzel, Y., Vogel, T., Buck, J., Behrendt, I., Schiedner, G., Jordan, I., & Reichl, U.High cell density cultivations for influenza virus production using suspension cellsPresented at: Vaccine Technology IVAlbufeira, Portugal, May 20, 2012.
2011
Talk
Genzel, Y., Janke, R., Isken, B., Rödig, J., Rapp, E., Lohr, V., Behrendt, I., Scharfenberg, K., Kamen, A., Schiedner, G., Jordan, I., & Reichl, U.Influenza virus production: characteristics of different producer cell linesPresented at: 10th PEACe 2011Cascais, Portugal, September 25, 2011.

Poster (12)

2022
Poster
Zinnecker, T. M., Behrendt, I., Lau , M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U.Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactorsPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.
Poster
Zinnecker, T. M., Behrendt, I., Lau, M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U.Suspension MDCK cell line development by automated single-cell cloning & scale-down into ambr®15 microbioreactors in chemically defined mediumPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.
Go to Editor View